CERTOLIZUMAB (CIMZIA)
Certolizumab is an anti-TNF agent that is given IV and has similar indications, effectiveness and side effects to adalimumab and the other anti-TNF agents.
Because of the drug's structure, it does not cross the placenta to a baby in the womb.
This article, as well as all others, was reviewed and edited by a member of our Medical Advisory Board.
Subscribe Be the first to know